In a non‑pregnant adult with a documented penicillin allergy, can ceftriaxone be used to treat syphilis and what are the recommended dosing regimens for early syphilis versus late latent or neurosyphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone for Syphilis in Penicillin-Allergic Patients

In non-pregnant adults with documented penicillin allergy, ceftriaxone 1 gram IM or IV daily for 10-14 days is an acceptable alternative for early syphilis (primary, secondary, or early latent), but penicillin desensitization remains the gold standard when feasible. 1, 2

Critical First Step: Exclude Pregnancy and Neurosyphilis

Before considering ceftriaxone, you must:

  • Confirm the patient is not pregnant – ceftriaxone is absolutely contraindicated in pregnancy; all pregnant patients require penicillin desensitization without exception 1, 3
  • Perform CSF examination if any of the following are present: neurologic or ophthalmic symptoms, evidence of tertiary syphilis, treatment failure, HIV infection with late latent disease, or nontreponemal titer ≥1:32 1, 4
  • If neurosyphilis is present, ceftriaxone 2 grams IV daily for 10-14 days may be considered, but data are extremely limited and penicillin desensitization is strongly preferred 5, 1

Dosing Regimens by Stage

Early Syphilis (Primary, Secondary, or Early Latent ≤1 Year)

Ceftriaxone 1 gram IM or IV daily for 10-14 days 1, 2

  • A 2017 multicenter randomized trial in 301 immunocompetent adults demonstrated that ceftriaxone 1 gram IV daily for 10 days achieved a 90.2% serological response rate at 6 months versus 78.0% with benzathine penicillin (p=0.01) 2
  • For secondary syphilis specifically, ceftriaxone showed superior response rates (95.8% vs 76.2%, p<0.01) 2
  • Single-dose ceftriaxone is completely ineffective – the full 10-14 day course is mandatory 5, 1

Late Latent Syphilis or Syphilis of Unknown Duration

Evidence for ceftriaxone in late latent disease is extremely limited 1

  • The optimal approach is doxycycline 100 mg orally twice daily for 28 days after CSF examination excludes neurosyphilis 1, 3
  • If doxycycline is contraindicated, consider penicillin desensitization rather than ceftriaxone, as there are no adequate data supporting ceftriaxone for late latent disease 1

Neurosyphilis (If Desensitization Not Feasible)

Ceftriaxone 2 grams IV daily for 10-14 days 5, 1

  • This regimen has very limited supporting data from small case series only 5, 1
  • The standard remains aqueous crystalline penicillin G 18-24 million units IV daily for 10-14 days 1, 4
  • Critical caveat: 10-15% cross-reactivity exists between penicillin and ceftriaxone due to shared beta-lactam structure 1

Key Limitations and Warnings

Cross-Reactivity Risk

  • Patients with severe penicillin reactions (Stevens-Johnson syndrome, anaphylaxis) may also react to ceftriaxone 1, 6
  • One case report documented successful use of ceftriaxone in a pregnant woman with penicillin-induced Stevens-Johnson syndrome, but this required intensive monitoring and is not standard practice 6

Insufficient Evidence for Specific Populations

  • Late latent syphilis: Optimal dose and duration not established; very limited data 5, 1
  • Tertiary syphilis: No adequate evidence base 1
  • HIV-infected patients: Limited data, though one retrospective study of 49 HIV-positive patients showed comparable efficacy to penicillin 7

Follow-Up Requirements

Because ceftriaxone data are limited compared to penicillin, more intensive monitoring is essential:

  • Quantitative nontreponemal tests (RPR or VDRL) at 6,12, and 24 months 1, 4
  • For HIV-infected patients: add testing at 3 and 9 months 1, 4
  • Treatment success = ≥4-fold decline in titer within 6 months for early syphilis or 12-24 months for late latent disease 1, 4

Treatment Failure Indicators

  • Persistent or recurrent symptoms 1, 4
  • Sustained 4-fold increase in nontreponemal titers 1, 4
  • Failure of initially high titer to decline 4-fold within expected timeframe 1, 4
  • If failure occurs: perform CSF examination and retreat with IV penicillin regimen for neurosyphilis 1, 4

Alternative to Ceftriaxone: Doxycycline

For non-pregnant, penicillin-allergic patients without neurosyphilis, doxycycline is often preferred over ceftriaxone:

  • Early syphilis: Doxycycline 100 mg orally twice daily for 14 days 1, 3
  • Late latent syphilis: Doxycycline 100 mg orally twice daily for 28 days (after CSF examination) 1, 3
  • Doxycycline has more extensive clinical experience than ceftriaxone and avoids beta-lactam cross-reactivity 1, 3

Common Pitfalls to Avoid

  1. Never use ceftriaxone in pregnancy – desensitization to penicillin is mandatory 1, 3
  2. Never use single-dose ceftriaxone – it is completely ineffective 5, 1
  3. Never skip CSF examination before treating late latent syphilis with non-penicillin regimens – undiagnosed neurosyphilis will not respond 1, 4
  4. Never assume ceftriaxone is safe in patients with severe penicillin reactions – cross-reactivity can occur 1, 6
  5. Never use azithromycin – widespread macrolide resistance makes it unreliable 1

When Penicillin Desensitization Is Preferred

Despite ceftriaxone being an option, penicillin desensitization followed by standard penicillin therapy is preferred when:

  • The patient is pregnant 1, 3
  • Neurosyphilis is present 5, 1
  • Late latent or tertiary syphilis requires treatment 1
  • Patient compliance with oral doxycycline is uncertain 1
  • Severe penicillin allergy raises concern about ceftriaxone cross-reactivity 1

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A Multicenter Study Evaluating Ceftriaxone and Benzathine Penicillin G as Treatment Agents for Early Syphilis in Jiangsu, China.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Guideline

Treatment of Syphilis When Penicillin G is Unavailable

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Latent Syphilis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can ceftriaxone (Ceftriaxone) treat syphilis?
Can ceftriaxone (a third-generation cephalosporin) administered intramuscularly (IM) be used as a treatment for syphilis infection in patients allergic to penicillin?
What is the latency period for symptoms of syphilis (Sexually Transmitted Infection) to appear?
Can intramuscular ceftriaxone replace benzathine penicillin G for treating recent primary, secondary, or early latent syphilis, especially in pregnant or penicillin‑allergic patients?
What is the expected syphilis titre (Venereal Disease Research Laboratory test) after treatment for syphilis?
Would lurasidone (Latuda) and fluoxetine (Prozac) help treat trauma‑related depression with hallucinations?
What is the significance of a false‑positive anti‑Ku antibody result and how should it be evaluated and managed?
What are the differential diagnoses for a recurrent, painless, localized red eye that persists for about a month in the same quadrant?
What is the basic mechanism of acidosis in acute kidney injury?
How can I stage and explain in simple terms an echocardiogram that shows left ventricular ejection fraction 40‑45 % with global hypokinesis, grade I diastolic dysfunction, normal right ventricle and atria, trace mitral, tricuspid and aortic regurgitation, normal right‑ventricular systolic pressure, aortic atherosclerosis, and normal inferior vena cava collapse?
Is platelet‑rich plasma (PRP) appropriate for an adult with mild‑to‑moderate knee osteoarthritis (Kellgren‑Lawrence grade II‑III) after failure of weight control, exercise, NSAIDs, physical therapy, and intra‑articular corticosteroids or hyaluronic acid, and what protocol, expected benefits, risks, and contraindications should be considered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.